In 2019, Robert Stewart earned $950.00K in total compensation at Amneal Pharmaceuticals, Inc., including $500.00K salary, $100.00K bonus and $300.00K in stock. Most recently acquired 10,000 shares in May 2023. Currently holds stock worth $7.29M. Led Amneal Pharmaceuticals, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Robert Stewart, including salary, bonuses, and stock awards.
Year
2019
Total Compensation
$950.00K
Salary
$500.00K
Bonus
$100.00K
Other
$50.00K
Salary
$500.00KBoard Justification
The compensation philosophy aims to align CEO compensation with company performance and shareholder interests, using a mix of fixed and variable pay components.
Bonus
$100.00KBoard Justification
The bonus is based on the achievement of specific financial performance metrics set by the Board of Directors for the fiscal year 2019.
Other Compensation
$50.00KBoard Justification
Other compensation includes retirement contributions and health benefits provided to the CEO.
Restricted Stock
Board Justification
The vested stock consists of restricted stock units (RSUs) that were granted in previous years and vested in 2019.
Performance Metrics
The performance metrics for 2019 included revenue growth and adjusted EBITDA targets.
Robert Stewart
Ex-CEO of Amneal Pharmaceuticals, Inc.
Education
Bachelor's degree in Pharmacy from the University of Southern California.
Sector of Economy
Healthcare
Born
January 1, 1963 - 62 years ago
CEO of Amneal Pharmaceuticals, Inc. for
1 year 2 months (May 2018 - Aug 2019)
Previous Experience
Former President and Chief Executive Officer at Impax Laboratories, Inc.
Other Amneal Pharmaceuticals, Inc. CEOs
Holdings
Track Robert Stewart's stock holdings and portfolio value over time.
Insider Trading
Robert Stewart's recent stock transactions, purchases, and sales filed with the SEC.
$43.74K
CRMD at $4.37/share
May 17, 2023
Purchase
$43.74K
CRMD at $4.37/share
May 17, 2023
Received
$202.64K
AMRX at $11.92/share
Mar 12, 2019
Purchase
4,568 shares
ACT
Mar 5, 2015
Received
$666.62K
ACT at $197.05/share
May 9, 2014
Received
$1.33M
ACT at $166.02/share
Dec 9, 2013
Sale
$1.64M
ACT at $164.44/share
Nov 15, 2013
Sale
$1.90M
ACT at $158.39/share
Nov 11, 2013
Sale
71,252 shares
ACT
Oct 1, 2013
Received
44,312 shares
ACT
Sep 30, 2013
Received
Rivals
Compare Robert Stewart with competitor CEOs and industry peers.